Dr. Lazaros J. Lekakis, MD

  • Miami, FL
  • Hematologist and oncologist
NPI1326067596PAC ID0547267544
Medicare services, 2024
233
Medicare patients, 2024
77
Part D claims, 2024
45
Publications
88
Clinical trials
10
Practice address
1475 Nw 12th Ave, Miami, FL 33136
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Sylvester Comprehensive Cancer Center

Hospital · Miami, Florida

Find Dr. Lekakis' professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Lazaros J. Lekakis is a hematologist and oncologist in Miami, Florida

Dr. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Lekakis' NPI, 1326067596, was assigned on July 19, 2006. Dr. Lekakis graduated from University of Athens in 1995. Dr. Lekakis holds Florida license ME108303.

NPI and contact details
Medicare PAC ID
0547267544
NPI enumeration date
July 19, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
57
Medical school graduation
1995

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Lazaros J. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida

Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Source: Dmand AI Affiliation Data

Dr. Lazaros J. Lekakis is affiliated with 1 site of care and 1 medical group

Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Lazaros J. Lekakis' practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lekakis practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sylvester Comprehensive Cancer CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lekakis practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Lazaros J. Lekakis is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Lekakis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lekakis is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lekakis' licenses on file in 3 states: Florida, Kentucky and Illinois.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME108303 · 2010 to 2027 · taxonomy 207RH0003X
  • Kentucky license2006 to 2011
  • Illinois license1999 to 2002

Clinical focus

Dmand AI lists anemia, chronic leukemia, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Lekakis treats.

Hematologists and oncologists near Dr. Lekakis

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Lazaros J. Lekakis billed Medicare for 233 services in 2024

CMS data shows 233 Medicare services from Dr. Lekakis across 3 procedure codes in 2024, for 77 Medicare patients. Medicare paid $21,981 for them.

Medicare services, 2024233
Medicare patients77
Paid by Medicare$21,981
Procedure codes3

Dr. Lekakis' Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2982024: 23322%

Where Dr. Lekakis' Medicare services took place, 2024

  • In an office9942%
  • In a facility13458%

Dr. Lekakis compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Lekakis
  • Florida median
Medicare services
233vs 69767% below
Medicare patients
77vs 21865% below
Part D claims
13vs 34196% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Lekakis' most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lekakis

Need commercial claims for Dr. Lekakis?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lekakis and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Lazaros J. Lekakis treated 77 Medicare patients in 2024, average age 66

CMS counts 77 Medicare patients who saw Dr. Lekakis in 2024. The largest group is 65 to 74, with 38 patients. 68% of them have high blood pressure, and 68% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lekakis' median patient age at 68, with 38% women.

Medicare patients, 202477
Average age66
Average risk score3.77
Also on Medicaid36%

Dr. Lekakis' Medicare patients by age, 2024

Dr. Lekakis' Medicare patients by sex, 2024

  • Women4255%
  • Men3545%

Chronic conditions among Dr. Lekakis' Medicare patients, 2024

  1. High blood pressure68%
  2. High cholesterol68%
  3. Arthritis44%
  4. Chronic kidney disease35%
  5. Diabetes35%
  6. Anxiety34%
  7. Mood disorders34%
  8. Ischemic heart disease30%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lekakis' patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women38%
  • Men62%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Lazaros J. Lekakis wrote 45 Medicare Part D claims in 2024

In 2024, Dr. Lekakis wrote 45 Medicare Part D claims for 18 patients. 62% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $124 in total drug cost. In 2020, CMS named 17 claims across 1 drug.

Part D claims, 202445
Drugs named by CMS1
Total drug cost$124
Part D patients18

Dr. Lekakis' Part D claims by kind of drug, 2024

  • Generic28 claims62%
  • Brand-name17 claims38%

Dr. Lekakis' most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2021

  • 2020
  • 2021
Claims for drugs CMS names
2020: 172021: 1324%

Drugs named by CMS: 1 in 2021, 1 in 2020.

See all prescribing by Dr. Lekakis

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Lazaros J. Lekakis scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lekakis for performance year 2024, reported individually. Dr. Lekakis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lekakis as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lekakis' MIPS scores, performance year 2024

  • 100of 100Final score
  • 93.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lekakis by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Lazaros J. Lekakis has 88 publications on record

Dmand AI links 88 papers to Dr. Lekakis, published from 2009 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Hematopoietic Stem Cell Transplantation, Lymphoma, Large B-Cell, Diffuse and Immunotherapy, Adoptive. Dr. Lekakis has published most often in Blood Adv. Dr. Lekakis' most frequent co-authors are Frederick Lundry Locke, MD, Amer M. Beitinjaneh, MD and Sattva S. Neelapu, MD.

Papers88
Years published2009 to 2025

Dr. Lekakis' papers by year, 2016 to 2025

Topics Dr. Lekakis writes about most

  • Hematopoietic Stem Cell Transplantation
  • Lymphoma, Large B-Cell, Diffuse
  • Immunotherapy, Adoptive
  • Receptors, Chimeric Antigen
  • Antigens, CD19
  • Biological Products
  • Transplantation, Autologous
  • Antineoplastic Combined Chemotherapy Protocols

Dr. Lekakis' most frequent co-authors

Recent publications by Dr. Lekakis

See all 88 publications and co-authors

See who Dr. Lekakis researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lekakis works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Lazaros J. Lekakis has worked on 10 clinical trials

Dmand AI links Dr. Lekakis to 10 clinical trials, 3 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse and Anemia, Sickle Cell. Emory University sponsors the most, 2.

Clinical trials with Dr. Lekakis by phase

  1. 1Phase 1: 1 trial
  2. 2Phase 1/2: 2 trials
  3. 3Phase 2: 3 trials
  4. 1Phase 3: 1 trial
  5. NonePhase 4: no trials

Conditions in Dr. Lekakis' trials

  • Lymphoma, B-Cell
  • Lymphoma, Large B-Cell, Diffuse
  • Anemia, Sickle Cell
  • Lymphoma, Non-Hodgkin
  • Carcinoma, Ovarian Epithelial

Investigators on the most trials with Dr. Lekakis

Recent clinical trials with Dr. Lekakis

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Lazaros J. Lekakis received $42,989 in industry payments from 2016 to 2025

CMS Open Payments shows 206 general payments to Dr. Lekakis from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Kite Pharma, Inc. paid the most, $15,471.

General payments to Dr. Lekakis by program year, 2016 to 2025

General payments to Dr. Lekakis by kind, 2016 to 2025

$43Kin total
  • Consulting fees$33,16077%
  • Food and beverage$6,78716%
  • Travel and lodging$2,4236%
  • Education$6191%

Companies that paid Dr. Lekakis the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lekakis

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Lazaros J. Lekakis has 1 award and honors on record

Dmand AI lists 1 award for Dr. Lekakis, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Lekakis

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Lazaros J. Lekakis graduated from University of Athens

Dr. Lekakis graduated from University of Athens in 1995.

  1. Medical schoolUniversity of Athens
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Lazaros J. Lekakis accepts plans from 11 insurance carriers

Dr. Lekakis is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Molina
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • Cigna
  • +3 more carriersWith a free account

Plan types Dr. Lekakis accepts, by number of carriers

  1. PPO7
  2. HMO5
  3. Medicare5
  4. POS5
  5. EPO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Lazaros J. Lekakis's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Lazaros J. Lekakis

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Lazaros J. Lekakis' NPI number?

Dr. Lazaros J. Lekakis' NPI number is 1326067596. It was assigned on July 19, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Lazaros J. Lekakis?

Dr. Lazaros J. Lekakis is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Lazaros J. Lekakis practice?

Dr. Lekakis practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Lekakis' primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

What is Dr. Lazaros J. Lekakis' medical license number?

Dr. Lekakis holds Florida license ME108303, one of the licenses on file in 3 states.

Which states has Dr. Lazaros J. Lekakis been licensed in?

Dmand AI has state licenses on file for Dr. Lekakis in Florida (2010 to 2027), Kentucky (2006 to 2011) and Illinois (1999 to 2002).

Which hospitals is Dr. Lazaros J. Lekakis affiliated with?

Dr. Lekakis practices at Sylvester Comprehensive Cancer Center in Miami, Florida.

What medical group is Dr. Lazaros J. Lekakis part of?

Dr. Lekakis is linked to University of Miami Health System.

Does Dr. Lazaros J. Lekakis accept Medicare?

Yes. CMS data shows Dr. Lekakis billed Medicare for 233 services in 2024, and Dr. Lekakis accepts Medicare assignment.

Does Dr. Lazaros J. Lekakis offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lekakis as offering telehealth services.

What is Dr. Lazaros J. Lekakis' MIPS score?

Dr. Lekakis' MIPS final score for performance year 2024 is 100 out of 100, reported individually.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Lazaros J. Lekakis see?

CMS counts 77 Medicare patients who saw Dr. Lekakis in 2024, with an average age of 66.

Is Dr. Lazaros J. Lekakis board certified?

Yes. Dr. Lekakis is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Lazaros J. Lekakis bill to Medicare?

In 2024, Dr. Lekakis' most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and hospital inpatient care (99233).

Where did Dr. Lazaros J. Lekakis go to medical school?

Dr. Lekakis graduated from University of Athens in 1995.

What drugs does Dr. Lazaros J. Lekakis prescribe most?

In 2021 Medicare Part D data, Dr. Lekakis' most prescribed drugs by claims were Zolpidem Tartrate.

Has Dr. Lazaros J. Lekakis received payments from drug or device companies?

CMS Open Payments shows $42,989 in general payments to Dr. Lekakis from 26 companies from 2016 to 2025. The largest total came from Kite Pharma, Inc.

How long has Dr. Lazaros J. Lekakis been practicing?

Dr. Lekakis graduated from medical school in 1995, 31 years ago.

Does Dr. Lazaros J. Lekakis do research?

Dmand AI links 88 publications to Dr. Lekakis, published from 2009 to 2025. Dr. Lekakis has worked on 10 clinical trials.

Who does Dr. Lazaros J. Lekakis publish with?

Dr. Lekakis' most frequent co-authors are Frederick Lundry Locke, MD (19 shared papers), Amer M. Beitinjaneh, MD (18 shared papers) and Sattva S. Neelapu, MD (16 shared papers).

What insurance does Dr. Lazaros J. Lekakis accept?

Dr. Lekakis is in network with 11 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)